» Articles » PMID: 22137022

Cosmetic Outcomes and Complications Reported by Patients Having Undergone Breast-conserving Treatment

Overview
Specialties Oncology
Radiology
Date 2011 Dec 6
PMID 22137022
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Over the past 30 years, much work in treatment of breast cancer has contributed to improvement of cosmetic and functional outcomes. The goal of breast-conservation treatment (BCT) is avoidance of mastectomy through use of lumpectomy and adjuvant radiation. Modern data demonstrate "excellent" or "good" cosmesis in >90% of patients treated with BCT.

Methods And Materials: Patient-reported data were gathered via a convenience sample frame from breast cancer survivors using a publically available, free, Internet-based tool for creation of survivorship care plans. During use of the tool, breast cancer survivors are queried as to the cosmetic appearance of the treated breast, as well as perceived late effects. All data have been maintained anonymously with internal review board approval.

Results: Three hundred fifty-four breast cancer survivors having undergone BCT and voluntarily using this tool were queried with regard to breast cosmesis and perceived late effects. Median diagnosis age was 48 years, and median current age 52 years. "Excellent" cosmesis was reported by 27% (n = 88), "Good" by 44% (n = 144), "Fair" by 24% (n = 81), and "Poor" by 5% (n = 18). Of the queries posted to survivors after BCT, late effects most commonly reported were cognitive changes (62%); sexual concerns (52%); changes in texture and color of irradiated skin (48%); chronic pain, numbness, or tingling (35%); and loss of flexibility in the irradiated area (30%). Survivors also described osteopenia/osteoporosis (35%), cardiopulmonary problems (12%), and lymphedema (19%).

Conclusions: This anonymous tool uses a convenience sample frame to gather patient reported assessments of cosmesis and complications after breast cancer. Among the BCT population, cosmetic assessment by survivors appears less likely to be "excellent" or "good" than would be expected, with 30% of BCT survivors reporting "fair" or "poor" cosmesis. Patient reported incidence of chronic pain, as well as cognitive and sexual changes, also appears higher than expected.

Citing Articles

Low-Cost Radio-Opaque Tumor Marking Techniques for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: a Systematic Review.

Bharath S, Yadav S, Sharma D Indian J Surg Oncol. 2024; 15(1):103-107.

PMID: 38511036 PMC: 10948646. DOI: 10.1007/s13193-023-01845-2.


The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review.

Ferrarazzo G, Nieri A, Firpo E, Rattaro A, Mignone A, Guasone F Curr Oncol. 2023; 30(10):8703-8719.

PMID: 37887530 PMC: 10605278. DOI: 10.3390/curroncol30100630.


De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.

van Hemert A, van Olmen J, Boersma L, Maduro J, Russell N, Tol J Breast Cancer Res Treat. 2023; 199(1):81-89.

PMID: 36892723 DOI: 10.1007/s10549-023-06899-y.


Accuracy of patient setup positioning using surface-guided radiotherapy with deformable registration in cases of surface deformation.

Kadman B, Takemura A, Ito T, Okada N, Kojima H, Ueda S J Appl Clin Med Phys. 2022; 23(3):e13493.

PMID: 35077004 PMC: 9398221. DOI: 10.1002/acm2.13493.


Does Tumor Marking Before Neoadjuvant Chemotherapy Helps Achieve Better Outcomes in Patients Undergoing Breast Conservative Surgery? A Systematic Review.

Jha C, Johri G, Singh P, Yadav S, Sinha U Indian J Surg Oncol. 2021; 12(3):624-631.

PMID: 34658593 PMC: 8490601. DOI: 10.1007/s13193-021-01393-7.